+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Enhanced virus clearance and prevention of CTL exhaustion by early inducible lymphocytic choriomeningitis virus specific neutralizing antibodies



Enhanced virus clearance and prevention of CTL exhaustion by early inducible lymphocytic choriomeningitis virus specific neutralizing antibodies



Immunology Letters 56(Part-P1): 26-27




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 062611410

Download citation: RISBibTeXText

DOI: 10.1016/s0165-2478(97)85101-2


Related references

Enhanced virus clearance by early inducible lymphocytic choriomeningitis virus-neutralizing antibodies in immunoglobulin-transgenic mice. Journal of Virology 72(3): 2253-2258, 1998

Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus. Journal of Virology 81(21): 11650-7, 2007

Lymphocytic choriomeningitis virus glycoprotein expressed in vaccinia virus allows h 2 restricted lymphocytic choriomeningitis virus specific cytotoxic t lymphocyte recognition lysis. Federation Proceedings 45(4): 979, 1986

Mechanism of recovery from acute virus infection. IX. Clearance of lymphocytic choriomeningitis (LCM) virus from the feet of mice undergoing LCM virus-specific delayed-type hypersensitivity reaction. Journal of General Virology 70: 3305-3316, 1989

Mechanism of recovery from acute virus infection treatment of lymphocytic choriomeningitis virus infected mice with monoclonal antibodies reveals that lyt 2+ t lymphocytes mediate clearance of virus and regulate the antiviral antibody response. Journal of Virology 61(6): 1867-1874, 1987

Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. Journal of Virology 51(3): 682-686, 1984

Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus and in vitro properties. Journal of Virology 53(2): 552-560, 1985

A study of human sera antibodies capable of neutralizing the virus of lymphocytic choriomeningitis. Publ Health Repts 54(22): 938-944, 1939

Significance of complement-fixing & neutralizing antibodies for the diagnosis of lymphocytic choriomeningitis virus infections. Deutsche Medizinische Wochenschrift 84(29): 1293-1296, 1959

Different isotype profiles of virus-specific antibodies in acute and persistent lymphocytic choriomeningitis virus infection in mice. Immunology 55(2): 213-223, 1985

Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread. Journal of Experimental Medicine 203(8): 2033-2042, 2006

Quantitation of lymphocytic choriomeningitis virus and serum neutralizing antibodies by immuno fluorescent cell counting. Abstracts of the Annual Meeting of the American Society for Microbiology 74: 213, 1974

Virus specificity of cytotoxic T lymphocytes generated during acute lymphocytic choriomeningitis virus infection: role of the H-2 region in determining cross-reactivity for different lymphocytic choriomeningitis virus strains. Journal of Virology 51(1): 34-41, 1984

Neutralizing serum antibodies of man after infections with the virus of lymphocytic choriomeningitis and the behavior of normal sera in the neutralization test. Archiv für die Gesamte Virusforschung 9: 295-309, 1959

In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody. Journal of Immunology 162(8): 4536-4541, 1999